SHORT REPORT

The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency

M Chol¹, S Lebon¹, P Bénit¹, D Chretien¹, P de Lonlay¹, A Goldenberg¹, S Odent², L Hertz-Pannier¹, C Vincent-Delorme¹, V Cormier-Daire¹, P Rustin¹, A Rötig¹, A Munnich¹

¹ INSERM U393 and Department of Genetics and Department of Paediatric Radiology, Hôpital Necker-Enfants Malades, 149 rue de Sévres, 75015 Paris, France
² Clinical Genetic Unit, Hôpital Pontchaillou, 35000 Rennes, France

Correspondence to:
Correspondence to:
Dr A Munnich, INSERM U393 and Department of Genetics and Department of Paediatric Radiology, Hôpital Necker-Enfants Malades, 149 rue de Sévres, 75015 Paris, France;
munnich{at}necker.fr

Leigh syndrome is a subacute necrotising encephalomyopathy frequently ascribed to mitochondrial respiratory chain deficiency. This condition is genetically heterogeneous, as mutations in both mitochondrial (mt) and nuclear genes have been reported. Here, we report the G13513A transition in the ND5 mtDNA gene in three unrelated children with complex I deficiency and a peculiar MRI aspect distinct from typical Leigh syndrome. Brain MRI consistently showed a specific involvement of the substantia nigra and medulla oblongata sparing the basal ganglia. Variable degrees of heteroplasmy were found in all tissues tested and a high percentage of mutant mtDNA was observed in muscle. The asymptomatic mothers presented low levels of mutant mtDNA in blood leucocytes. This mutation, which affects an evolutionary conserved amino acid (D393N), has been previously reported in adult patients with MELAS or LHON/MELAS syndromes, emphasising the clinical heterogeneity of mitochondrial DNA mutations. Since the G13513A mutation was found in 21% of our patients with Leigh syndrome and complex I deficiency (3/14), it appears that this mutation represents a frequent cause of Leigh-like syndrome, which should be systematically tested for molecular diagnosis in affected children and for genetic counselling in their maternal relatives.

Keywords: G13513A; Leigh disease; NADH; mitochondrial DNA

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Rahman, S, Hanna, M G (2009). Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. J. Neurol. Neurosurg. Psychiatry 80: 943-953 [Abstract] [Full Text]  
• Byung Chan Lim, , Jun Dong Park, , Hwang, H., Ki Joong Kim, , Yong Seung Hwang, , Chae, J.-H., Cheon, J.-E., In One Kim, , Lee, R., Han Ku Moon, (2009). Mutations in ND Subunits of Complex I Are an Important Genetic Cause of Childhood Mitochondrial Encephalopathies. J Child Neurol 24: 828-832 [Abstract]  
• Menzies, K. J., Robinson, B. H., Hood, D. A. (2009). Effect of thyroid hormone on mitochondrial properties and oxidative stress in cells from patients with mtDNA defects. Am. J. Physiol. Cell Physiol. 296: C355-C362 [Abstract] [Full Text]  
• Shanske, S., Coku, J., Lu, J., Ganesh, J., Krishna, S., Tanji, K., Bonilla, E., Naini, A. B., Hirano, M., DiMauro, S. (2008). The G13513A Mutation in the ND5 Gene of Mitochondrial DNA as a Common Cause of MELAS or Leigh Syndrome: Evidence From 12 Cases. Arch Neurol 65: 368-372 [Abstract] [Full Text]  
• Blok, M J, Spruijt, L, de Coo, I F M, Schoonderwoerd, K, Hendrickx, A, Smeets, H J (2007). Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease. J. Med. Genet. 44: e74-e74 [Abstract] [Full Text]  
• Valentino, M L, Barboni, P, Rengo, C, Achilli, A, Torroni, A, Lodi, R, Tonon, C, Barbiroli, B, Fortuna, F, Montagna, P, Baruzzi, A, Carelli, V (2006). The 13042G --> A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype.. J. Med. Genet. 43: e38-e38 [Abstract] [Full Text]  
• Dickerson, B. C., Holtzman, D., Grant, P. E., Tian, D. (2005). Case 36-2005 -- A 61-Year-Old Woman with Seizure, Disturbed Gait, and Altered Mental Status.. NEJM 353: 2271-2280 [Full Text]  
• Naini, A. B., Lu, J., Kaufmann, P., Bernstein, R. A., Mancuso, M., Bonilla, E., Hirano, M., DiMauro, S. (2005). Novel Mitochondrial DNA ND5 Mutation in a Patient With Clinical Features of MELAS and MERRF. Arch Neurol 62: 473-476 [Abstract] [Full Text]  
• Zeviani, M., Di Donato, S. (2004). Mitochondrial disorders. Brain 127: 2153-2172 [Abstract] [Full Text]  
• Lebon, S, Chol, M, Benit, P, Mugnier, C, Chretien, D, Giurgea, I, Kern, I, Girardin, E, Hertz-Pannier, L, de Lonlay, P, Rotig, A, Rustin, P, Munnich, A (2003). Recurrent de novo mitochondrial DNA mutations in respiratory chain deficiency. J. Med. Genet. 40: 896-899 [Abstract] [Full Text]